Divergent Inflammatory, Fibrogenic, and Liver Progenitor Cell Dynamics in Two Common Mouse Models of Chronic Liver Injury

American Journal of Pathology

Volumn 186, Issue 7, 2016, Pages 1762-1774

  Köhn Gaone, Julia ^a   Dwyer, Benjamin J ^a   Grzelak, Candice A ^b   Miller, Gregory ^c   Shackel, Nicholas A ^b,d   Ramm, Grant A ^c,e   McCaughan, Geoffrey W ^b,d,f   Elsegood, Caryn L ^a,g   Olynyk, John K ^a,h,i   Tirnitz Parker, Janina E E ^a,j  

^a CURTIN UNIVERSITY   (Australia)

^b CENTENARY INSTITUTE   (Australia)

^c UNIVERSITY OF QUEENSLAND   (Australia)

^d ROYAL PRINCE ALFRED HOSPITAL   (Australia)

^e QIMR BERGHOFER MEDICAL RESEARCH INSTITUTE   (Australia)

^f AW Morrow Gastroenterology and Liver Centre   (Australia)

^g UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^h FIONA STANLEY HOSPITAL   (Australia)

ⁱ MURDOCH UNIVERSITY   (Australia)

^j UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ETHIONINE; THIOACETAMIDE;

ALANINE AMINOTRANSFERASE BLOOD LEVEL; ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; CHRONIC DISEASE; COMPARATIVE STUDY; CONTROLLED STUDY; DIET SUPPLEMENTATION; DISEASE MARKER; DYNAMICS; FIBROGENESIS; INFLAMMATION; LIVER CELL; LIVER FIBROSIS; LIVER INJURY; MALE; MOUSE; NONHUMAN; OXIDATIVE STRESS; PHENOTYPE; PRIORITY JOURNAL; STEM CELL; VITAMIN DEFICIENCY; ANIMAL; C57BL MOUSE; DISEASE MODEL; IMMUNOHISTOCHEMISTRY; LIVER DISEASE; PATHOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY; REAL TIME POLYMERASE CHAIN REACTION;

ANIMALS; CHRONIC DISEASE; DISEASE MODELS, ANIMAL; HEPATOCYTES; IMMUNOHISTOCHEMISTRY; LIVER DISEASES; MALE; MICE; MICE, INBRED C57BL; REAL-TIME POLYMERASE CHAIN REACTION; STEM CELLS;

EID: 84997161425     PISSN: 00029440     EISSN: 15252191     Source Type: Journal    
DOI: 10.1016/j.ajpath.2016.03.005     Document Type: Article

References (48)

1. 1 Chen, C.L., Yang, H.I., Yang, W.S., Liu, C.J., Chen, P.J., You, S.L., Wang, L.Y., Sun, C.A., Lu, S.N., Chen, D.S., Chen, C.J., Metabolic factors and risk of hepatocellular carcinoma by chronic hepatitis B/C infection: a follow-up study in Taiwan. Gastroenterology 135 (2008), 111–121.
2. 2 Gouw, A.S., Clouston, A.D., Theise, N.D., Ductular reactions in human liver: diversity at the interface. Hepatology 54 (2011), 1853–1863.
3. 3 Williams, M.J., Clouston, A.D., Forbes, S.J., Links between hepatic fibrosis, ductular reaction, and progenitor cell expansion. Gastroenterology 146 (2014), 349–356.
4. 4 Forster, N., Palmer, J.A., Yeoh, G., Ong, W.C., Mitchell, G.M., Slavin, J., Tirnitz-Parker, J., Morrison, W.A., Expansion and hepatocytic differentiation of liver progenitor cells in vivo using a vascularized tissue engineering chamber in mice. Tissue Eng Part C Methods 17 (2011), 359–366.
5. 5 Lu, W.Y., Bird, T.G., Boulter, L., Tsuchiya, A., Cole, A.M., Hay, T., Guest, R.V., Wojtacha, D., Man, T.Y., Mackinnon, A., Ridgway, R.A., Kendall, T., Williams, M.J., Jamieson, T., Raven, A., Hay, D.C., Iredale, J.P., Clarke, A.R., Sansom, O.J., Forbes, S.J., Hepatic progenitor cells of biliary origin with liver repopulation capacity. Nat Cell Biol 17 (2015), 971–983.
6. 6 Sackett, S.D., Li, Z., Hurtt, R., Gao, Y., Wells, R.G., Brondell, K., Kaestner, K.H., Greenbaum, L.E., Foxl1 is a marker of bipotential hepatic progenitor cells in mice. Hepatology 49 (2009), 920–929.
7. 7 Shin, S., Walton, G., Aoki, R., Brondell, K., Schug, J., Fox, A., Smirnova, O., Dorrell, C., Erker, L., Chu, A.S., Wells, R.G., Grompe, M., Greenbaum, L.E., Kaestner, K.H., Foxl1-Cre-marked adult hepatic progenitors have clonogenic and bilineage differentiation potential. Genes Dev 25 (2011), 1185–1192.
8. 8 Suzuki, A., Sekiya, S., Onishi, M., Oshima, N., Kiyonari, H., Nakauchi, H., Taniguchi, H., Flow cytometric isolation and clonal identification of self-renewing bipotent hepatic progenitor cells in adult mouse liver. Hepatology 48 (2008), 1964–1978.
9. 9 Kohn-Gaone, J., Gogoi-Tiwari, J., Ramm, G.A., Olynyk, J.K., Tirnitz-Parker, J.E., The role of liver progenitor cells during liver regeneration, fibrogenesis, and carcinogenesis. Am J Physiol Gastrointest Liver Physiol 310 (2016), G143–G154.
10. 10 Boulter, L., Lu, W.Y., Forbes, S.J., Differentiation of progenitors in the liver: a matter of local choice. J Clin Invest 123 (2013), 1867–1873.
11. 11 Dwyer, B.J., Olynyk, J.K., Ramm, G.A., Tirnitz-Parker, J.E., TWEAK and LTbeta Signaling during Chronic Liver Disease. Front Immunol, 5, 2014, 39.
12. 12 Grzelak, C.A., Martelotto, L.G., Sigglekow, N.D., Patkunanathan, B., Ajami, K., Calabro, S.R., Dwyer, B.J., Tirnitz-Parker, J.E., Watkins, D.N., Warner, F.J., Shackel, N.A., McCaughan, G.W., The intrahepatic signalling niche of hedgehog is defined by primary cilia positive cells during chronic liver injury. J Hepatol 60 (2014), 143–151.
13. 13 Ruddell, R.G., Knight, B., Tirnitz-Parker, J.E., Akhurst, B., Summerville, L., Subramaniam, V.N., Olynyk, J.K., Ramm, G.A., Lymphotoxin-beta receptor signaling regulates hepatic stellate cell function and wound healing in a murine model of chronic liver injury. Hepatology 49 (2009), 227–239.
14. 14 Tirnitz-Parker, J.E., Olynyk, J.K., Ramm, G.A., Role of TWEAK in coregulating liver progenitor cell and fibrogenic responses. Hepatology 59 (2014), 1198–1201.
15. 15 Dan, Y.Y., Yeoh, G.C., Liver stem cells: a scientific and clinical perspective. J Gastroenterol Hepatol 23 (2008), 687–698.
16. 16 Clouston, A.D., Powell, E.E., Walsh, M.J., Richardson, M.M., Demetris, A.J., Jonsson, J.R., Fibrosis correlates with a ductular reaction in hepatitis C: roles of impaired replication, progenitor cells and steatosis. Hepatology 41 (2005), 809–818.
17. 17 Lowes, K.N., Brennan, B.A., Yeoh, G.C., Olynyk, J.K., Oval cell numbers in human chronic liver diseases are directly related to disease severity. Am J Pathol 154 (1999), 537–541.
18. 18 Prakoso, E., Tirnitz-Parker, J.E., Clouston, A.D., Kayali, Z., Lee, A., Gan, E.K., Ramm, G.A., Kench, J.G., Bowen, D.G., Olynyk, J.K., McCaughan, G.W., Shackel, N.A., Analysis of the intrahepatic ductular reaction and progenitor cell responses in hepatitis C virus recurrence after liver transplantation. Liver Transpl 20 (2014), 1508–1519.
19. 19 Wood, M.J., Gadd, V.L., Powell, L.W., Ramm, G.A., Clouston, A.D., Ductular reaction in hereditary hemochromatosis: the link between hepatocyte senescence and fibrosis progression. Hepatology 59 (2014), 848–857.
20. 20 Davies, R.A., Knight, B., Tian, Y.W., Yeoh, G.C., Olynyk, J.K., Hepatic oval cell response to the choline-deficient, ethionine supplemented model of murine liver injury is attenuated by the administration of a cyclo-oxygenase 2 inhibitor. Carcinogenesis 27 (2006), 1607–1616.
21. 21 Knight, B., Tirnitz-Parker, J.E., Olynyk, J.K., C-kit inhibition by imatinib mesylate attenuates progenitor cell expansion and inhibits liver tumor formation in mice. Gastroenterology 135 (2008), 969–979 979.e1.
22. 22 Lee, K.P., Lee, J.H., Kim, T.S., Kim, T.H., Park, H.D., Byun, J.S., Kim, M.C., Jeong, W.I., Calvisi, D.F., Kim, J.M., Lim, D.S., The Hippo-Salvador pathway restrains hepatic oval cell proliferation, liver size, and liver tumorigenesis. Proc Natl Acad Sci U S A 107 (2010), 8248–8253.
23. 23 Akhurst, B., Croager, E.J., Farley-Roche, C.A., Ong, J.K., Dumble, M.L., Knight, B., Yeoh, G.C., A modified choline-deficient, ethionine-supplemented diet protocol effectively induces oval cells in mouse liver. Hepatology 34 (2001), 519–522.
24. 24 Tirnitz-Parker, J.E., Viebahn, C.S., Jakubowski, A., Klopcic, B.R., Olynyk, J.K., Yeoh, G.C., Knight, B., Tumor necrosis factor-like weak inducer of apoptosis is a mitogen for liver progenitor cells. Hepatology 52 (2010), 291–302.
25. 25 Van Hul, N.K., Abarca-Quinones, J., Sempoux, C., Horsmans, Y., Leclercq, I.A., Relation between liver progenitor cell expansion and extracellular matrix deposition in a CDE-induced murine model of chronic liver injury. Hepatology 49 (2009), 1625–1635.
26. 26 Yao, Z.M., Vance, D.E., The active synthesis of phosphatidylcholine is required for very low density lipoprotein secretion from rat hepatocytes. J Biol Chem 263 (1988), 2998–3004.
27. 27 Hunter, A.L., Holscher, M.A., Neal, R.A., Thioacetamide-induced hepatic necrosis. I. Involvement of the mixed-function oxidase enzyme system. J Pharmacol Exp Ther 200 (1977), 439–448.
28. 28 Low, T.Y., Leow, C.K., Salto-Tellez, M., Chung, M.C., A proteomic analysis of thioacetamide-induced hepatotoxicity and cirrhosis in rat livers. Proteomics 4 (2004), 3960–3974.
29. 29 Boulter, L., Guest, R.V., Kendall, T.J., Wilson, D.H., Wojtacha, D., Robson, A.J., Ridgway, R.A., Samuel, K., Van Rooijen, N., Barry, S.T., Wigmore, S.J., Sansom, O.J., Forbes, S.J., WNT signaling drives cholangiocarcinoma growth and can be pharmacologically inhibited. J Clin Invest 125 (2015), 1269–1285.
30. 30 Guest, R.V., Boulter, L., Kendall, T.J., Minnis-Lyons, S.E., Walker, R., Wigmore, S.J., Sansom, O.J., Forbes, S.J., Cell lineage tracing reveals a biliary origin of intrahepatic cholangiocarcinoma. Cancer Res 74 (2014), 1005–1010.
31. 31 Biswas, M., Chan, J.Y., Role of Nrf1 in antioxidant response element-mediated gene expression and beyond. Toxicol Appl Pharmacol 244 (2010), 16–20.
32. 32 Okuyama, H., Nakamura, H., Shimahara, Y., Uyama, N., Kwon, Y.W., Kawada, N., Yamaoka, Y., Yodoi, J., Overexpression of thioredoxin prevents thioacetamide-induced hepatic fibrosis in mice. J Hepatol 42 (2005), 117–123.
33. 33 Hardwick, R.N., Fisher, C.D., Canet, M.J., Lake, A.D., Cherrington, N.J., Diversity in antioxidant response enzymes in progressive stages of human nonalcoholic fatty liver disease. Drug Metab Dispos 38 (2010), 2293–2301.
34. 34 Elsegood, C.L., Chan, C.W., Degli-Esposti, M.A., Wikstrom, M.E., Domenichini, A., Lazarus, K., van Rooijen, N., Ganss, R., Olynyk, J.K., Yeoh, G.C., Kupffer cell-monocyte communication is essential for initiating murine liver progenitor cell-mediated liver regeneration. Hepatology 62 (2015), 1272–1284.
35. 35 Kofman, A.V., Morgan, G., Kirschenbaum, A., Osbeck, J., Hussain, M., Swenson, S., Theise, N.D., Dose- and time-dependent oval cell reaction in acetaminophen-induced murine liver injury. Hepatology 41 (2005), 1252–1261.
36. 36 Darweish, M.M., Abbas, A., Ebrahim, M.A., Al-Gayyar, M.M., Chemopreventive and hepatoprotective effects of Epigallocatechin-gallate against hepatocellular carcinoma: role of heparan sulfate proteoglycans pathway. J Pharm Pharmacol 66 (2014), 1032–1045.
37. 37 Aharoni-Simon, M., Hann-Obercyger, M., Pen, S., Madar, Z., Tirosh, O., Fatty liver is associated with impaired activity of PPARgamma-coactivator 1alpha (PGC1alpha) and mitochondrial biogenesis in mice. Lab Invest 91 (2011), 1018–1028.
38. 38 Knight, B., Yeoh, G.C., TNF/LTalpha double knockout mice display abnormal inflammatory and regenerative responses to acute and chronic liver injury. Cell Tissue Res 319 (2005), 61–70.
39. 39 Matthews, V.B., Klinken, E., Yeoh, G.C., Direct effects of interleukin-6 on liver progenitor oval cells in culture. Wound Repair Regen 12 (2004), 650–656.
40. 40 Brooling, J.T., Campbell, J.S., Mitchell, C., Yeoh, G.C., Fausto, N., Differential regulation of rodent hepatocyte and oval cell proliferation by interferon gamma. Hepatology 41 (2005), 906–915.
41. 41 Ishikawa, T., Factor, V.M., Marquardt, J.U., Raggi, C., Seo, D., Kitade, M., Conner, E.A., Thorgeirsson, S.S., Hepatocyte growth factor/c-met signaling is required for stem-cell-mediated liver regeneration in mice. Hepatology 55 (2012), 1215–1226.
42. 42 Ferrell, L., Liver pathology: cirrhosis, hepatitis, and primary liver tumors. Update and diagnostic problems. Mod Pathol 13 (2000), 679–704.
43. 43 Aydin, A.F., Kusku-Kiraz, Z., Dogru-Abbasoglu, S., Gulluoglu, M., Uysal, M., Kocak-Toker, N., Effect of carnosine against thioacetamide-induced liver cirrhosis in rat. Peptides 31 (2010), 67–71.
44. 44 Kornek, M., Raskopf, E., Guetgemann, I., Ocker, M., Gerceker, S., Gonzalez-Carmona, M.A., Rabe, C., Sauerbruch, T., Schmitz, V., Combination of systemic thioacetamide (TAA) injections and ethanol feeding accelerates hepatic fibrosis in C3H/He mice and is associated with intrahepatic up regulation of MMP-2, VEGF and ICAM-1. J Hepatol 45 (2006), 370–376.
45. 45 Patsenker, E., Popov, Y., Stickel, F., Schneider, V., Ledermann, M., Sagesser, H., Niedobitek, G., Goodman, S.L., Schuppan, D., Pharmacological inhibition of integrin alphavbeta3 aggravates experimental liver fibrosis and suppresses hepatic angiogenesis. Hepatology 50 (2009), 1501–1511.
46. 46 Wallace, M.C., Hamesch, K., Lunova, M., Kim, Y., Weiskirchen, R., Strnad, P., Friedman, S.L., Standard operating procedures in experimental liver research: thioacetamide model in mice and rats. Lab Anim 49 (2015), 21–29.
47. 47 Gao, J.H., Wen, S.L., Yang, W.J., Lu, Y.Y., Tong, H., Huang, Z.Y., Liu, Z.X., Tang, C.W., Celecoxib ameliorates portal hypertension of the cirrhotic rats through the dual inhibitory effects on the intrahepatic fibrosis and angiogenesis. PLoS One, 8, 2013, e69309.
48. 48 Lee, T.Y., Chang, H.H., Wen, C.K., Huang, T.H., Chang, Y.S., Modulation of thioacetamide-induced hepatic inflammations, angiogenesis and fibrosis by andrographolide in mice. J Ethnopharmacol 158 Pt A (2014), 423–430.